Table 1 Patient and tumor characteristics
Characteristics | Overall (n = 123) |
|---|---|
Age (years), mean ± SD | 54.3 ± 7.6 |
Sex, n (%) | |
 Man | 117 (95.1) |
 Woman | 6 (4.9) |
ECOG performance status, n (%) | |
 0 | 105 (85.4) |
 1 | 18 (14.6) |
Pathology, n (%) | |
 SCC | 120 (97.6) |
 Adenocarcinoma | 3 (2.4) |
Location, n (%) | |
 Upper | 24 (19.5) |
 Middle | 59 (48.0) |
 Lower | 40 (32.5) |
BMI (kg/m2), mean ± SD | 22.1 ± 3.3 |
Histologic grade, n (%) | |
 Grade 1 | 12 (9.8) |
 Grade 2 | 88 (71.5) |
 Grade 3 | 23 (18.7) |
Smoking, n (%) | |
 No (never smoked or quitted) | 7 (5.7) |
 Yes (current smoker) | 116 (94.3) |
Clinical T stage, n (%) | |
 cT1 | 1 (0.8) |
 cT2 | 36 (29.3) |
 cT3 | 80 (65.0) |
 cT4a | 6 (4.9) |
Clinical N stage, n (%) | |
 cN0 | 14 (11.4) |
 cN1 | 57 (46.3) |
 cN2 | 39 (31.7) |
 cN3 | 13 (10.6) |
cTNM stage, n (%) | |
 II | 31 (25.2) |
 III | 92 (74.8) |
Gross tumor volume (ml), mean ± SD | 100.9 ± 73.2 |
Radiation dose (Gy), median (IQR) | 44.0 (43.2–45.0) |
 40–44 Gy, n(%) | 62 (50.4) |
 45–50.4 Gy, n(%) | 61 (49.6) |
Target volume (ml), mean ± SD | 527.6 ± 228.5 |
Dose-volume of lunga (%), mean ± SD | |
 V5 | 74.0 ± 21.2 |
 V20 | 20.8 ± 6.4 |
Mean heart dose (Gy), mean ± SD | 18.3 ± 7.6 |